000			01649 a2200457 4500
005			20250516223040.0
264		0	_c20160301
008			201603s 0 0 spa d
022			_a1578-8989
024	7		_a10.1016/j.medcli.2014.04.025 _2doi
040			_aNLM _beng _cNLM
100	1		_aNavarro Matilla, Belén
245	0	0	_a[Mantle cell lymphoma: Towards a personalized therapeutic strategy?]. _h[electronic resource]
260			_bMedicina clinica _cJun 2015
300			_a553-9 p. _bdigital
500			_aPublication Type: English Abstract; Journal Article; Review
650	0	4	_aAge Factors
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aCombined Modality Therapy
650	0	4	_aDiagnosis, Differential
650	0	4	_aDisease Progression
650	0	4	_aGenes, cdc
650	0	4	_aHematopoietic Stem Cell Transplantation
650	0	4	_aHumans
650	0	4	_aImmunologic Factors _xadministration & dosage
650	0	4	_aImmunophenotyping
650	0	4	_aImmunotherapy
650	0	4	_aLymphoma, Mantle-Cell _xdiagnosis
650	0	4	_aLymphoproliferative Disorders _xdiagnosis
650	0	4	_aMolecular Targeted Therapy
650	0	4	_aMutation
650	0	4	_aNeoplasm Proteins _xgenetics
650	0	4	_aPalliative Care
650	0	4	_aPrecision Medicine
650	0	4	_aProtein Kinase Inhibitors _xadministration & dosage
650	0	4	_aRadioimmunotherapy
650	0	4	_aSalvage Therapy
700	1		_aGarcía-Marco, José A
773	0		_tMedicina clinica _gvol. 144 _gno. 12 _gp. 553-9
856	4	0	_uhttps://doi.org/10.1016/j.medcli.2014.04.025 _zAvailable from publisher's website
999			_c24006508 _d24006508